Idexx Laboratories | IDXX - Ebitda

Stock Price
528.79
Daily Change
-4.07 -0.76%
Monthly
-7.22%
Yearly
2.06%
Q2 Forecast
518.16

Idexx Laboratories reported $400.87M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Accuray USD -685K 900K Sep/2024
Align Technology USD 260.87M 77.03M Dec/2025
AngioDynamics USD 5.94M 3.78M Sep/2025
Dentsply International USD 129M 6M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Fujifilm JPY 149.91B 17.19B Mar/2026
Globus Medical USD 280.46M 27.86M Dec/2025
Henry Schein USD 289M 2M Mar/2026
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
Masimo USD 85.5M 6.4M Mar/2026
Neogen USD 48.2M 546K Dec/2025
Orthofix International USD 27.88M 2.77M Dec/2025
Phibro Animal Health USD 68.1M 6.2M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Steris USD 394.7M 5M Dec/2025
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Zoetis USD 939M 101M Dec/2025